College of Arts and Sciences Department of Psychology
Vice Chancellor for Research
Washington State University Health Sciences Spokane
SAC 503M, Spokane
• Gender differences in opioid use
• The transition from pregnancy to parenthood in women with substance use disorders
• Perceptions of risks and benefits of cannabis use during pregnancy.
Management, Information Systems, and Entrepreneurship
TODD HALL 0437C
• Cultural Values
• Employee Wellbeing
• Workplace Fairness
Professor Emeritus, Retired
• I am interested in self-management theory and procedures. My research is focused on using these procedures to reduce the personal and societal costs of common self-control problems such as over consumption of alcohol, high-risk sexual behavior over eating, anger difficulties.
Department of Medical Education and Clinical Services
HERB 454, Spokane
• My research is broadly focused on the neuropsychology of type 1 diabetes. Currently funded projects include 1) ecological momentary assessment of cognition, emotion and stress, coupled with continuous glucose monitoring in adults with type 1 diabetes, and 2) a clinical trial of automated insulin delivery in older adults with type 1 diabetes with and without mild cognitive impairment. Other interests include the validation of mobile neuropsychological assessment and ecological validity of neuropsychological assessment in patients with chronic disease.
|Rebecca M. Craft|
Johnson Tower 209, Pullman
• Drug Abuse and Dependence
• Sex Differences in Drug Effects
• Hormonal Modulation of Pain, Analgesia and Mood
Associate Research Professor
Assistant Research Professor
CCRS 702D, Spokane
|Currently considering graduate students for the Experimental Psychology PhD Program.
• Sleep deprivation effects on cognition
• Sleep and performance in shiftworkers
• Fatigue risk management and shift schedules in transportation industries
• Health and performance during sleep restriction and recovery
Research Assistant Professor
• Sleep deprivation
• Decision making
• Metacognition and learning
Clinical Associate Professor
Elson S. Floyd College of Medicine
HSB 320F, Spokane
• Active research projects include the study of neuroactive steroid hormones known to modulate glutamate and GABA receptors during acute smoking cessation, as well as during psychostimulant withdrawal from methamphetamine, in comparison to healthy control subjects.
Associate Professor, Elson S. Floyd College of Medicine
Director, Behavioral Health Innovations
HERB 408, Spokane
• Dr. McDonell is a clinical psychologist with over 20 years of experience developing, testing, and implementing strength-based interventions for people with addiction and mental illness in community settings. He is an Associate Professor in the Elson S. Floyd College of Medicine and Director of the Behavioral Health Innovations research group in Spokane, Washington.
|Ryan J. McLaughlin|
Integrative Physiology and Neuroscience
VBR 235, Pullman
• A central aim of my research is to study the role of the endocannabinoid system in the neurophysiological and behavioral response to stressful and aversive stimuli, and subsequently, to determine the extent to which this system is involved in the etiology and treatment of stress-related illnesses. Additionally our laboratory has developed a novel, translationally-relevant model of cannabis vapor self-administration in rats, which we are currently using to interrogate the long-term effects of developmental cannabis exposure on the brain, behavior, and cognitive functioning.
Assistant Dean for Research
Director of Biostatistics and Clinical Trial Design
ROP 313, Spokane
• Development of evidence-based drug/alcohol use disorder treatments, including the use of experimental technologies;
• Innovative analytical methods to answer novel research questions in psychopharmacology, drug/alcohol use, and nephrology; and
• Drug/alcohol use disorders as a co-morbidity in high risk populations (e.g., kidney disease patients, severely mentally ill adults, and methadone maintained patients).
|Frances K. McSweeney|
Regents Professor, Retired
Johnson Tower 319, Pullman
• Operant and Classical Conditioning
• The Matching Law
• Behavioral Contrast
• Within-Session Changes in Responding
Associate Professor of Marketing and International Business
Director of Center for Behavioral Business Research
Todd 390, Pullman
• Consumer self-identity
• Implicit processes and behavior
• Embodied cognition
• Consumer behavior in virtual environments
Professor and Vice President for Research, Elson S. Floyd College of Medicine
Associate Vice President for Health Sciences Research WSU
SAC 503F, Spokane
Integrative Physiology and Neuroscience
VBR 355, Pullman
• Neural mechanisms of drug and alcohol abuse. In particular we use rodent models to study what predisposes (genetic or environment) individuals to abuse drugs and alcohol, how chronic abuse of drugs and alcohol affects the brain to promote and maintain further abuse, and how drugs and alcohol affect the developing brain.
Department of Translational Medicine and Physiology
Sleep and Performance Research Center
• Dr. Satterfield studies the complex phenotype-genotype associations between sleep and cognition. She uses functional genetic polymorphisms as a tool to understand the underlying neurobiological mechanisms associated with inter-individual differences in cognitive impairment during sleep loss. Recently, Dr. Satterfield has taken interest in investigating how circadian disruption increases the risk of poor health outcomes, including metabolic health and cancer.
Management Information Systems & Entrepreneurship
CL 308E, Vancouver
• Organizational Justice
• Workplace Conflict (including revenge and forgiveness)
|Hans Van Dongen|
Director, Sleep and Performance Research Center
Professor, Elson S. Floyd College of Medicine
CCRS 702C, Spokane
• Dr. Van Dongen's research portfolio is broad, including two particular focus areas in which he is recognized as an international leader. The first involves inter-individual differences in cognitive impairment resulting from sleep deprivation, which he showed to constitute a human phenotype. The second is mathematical and statistical modeling of performance impairment due to fatigue, and the application thereof in fatigue risk management systems.
|John W. Wright|
Regents Professor Emeritus, Retired
Johnson Tower 124, Pullman
• Alzheimer's Disease
• Neurochemistry of Memory Consolidation
• Parkinson's Disease
• Stroke related motor dysfunctions